Neogenomics, Inc.
NEO
$6.45
-$0.155-2.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -73.95% | -69.17% | 13.42% | 5.06% | 31.11% |
| Total Depreciation and Amortization | -2.62% | -2.53% | 1.13% | -0.67% | -0.88% |
| Total Amortization of Deferred Charges | -32.24% | 0.41% | 0.27% | 0.41% | 0.28% |
| Total Other Non-Cash Items | 171.89% | 20.45% | -4.37% | -7.67% | 13.39% |
| Change in Net Operating Assets | 146.34% | -643.05% | -61.89% | -221.86% | 107.34% |
| Cash from Operations | 180.27% | -358.44% | 5.99% | -33.44% | 153.61% |
| Capital Expenditure | -40.51% | 61.20% | -7.41% | 17.43% | -134.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.78% | 31.44% | -15.80% | -64.28% | 1.40% |
| Cash from Investing | -361.63% | 165.12% | -55.49% | -148.08% | -49.65% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -73.21% | 201.02% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -21,431.19% | 38.14% | -41.63% | -40.13% | 140.93% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -819.74% | -514.70% | -27.32% | -70.19% | 319.13% |